Pedro Castellano | Getty ImagesInvestors are bailing on biotech stocks at such a rapid pace that it is shocking even some of the most-seasoned traders. It’s a popping bubble that could have implications on the sustainability of this six-year bull market.Consider this, the most popular ETF in the sector—the Nasdaq Biotechnology iShares (IBB)—hit an all-time intraday high Friday of $374.62. […]
Pedro Castellano | Getty ImagesInvestors are bailing on biotech stocks at such a rapid pace that it is shocking even some of the most-seasoned traders. It’s a popping bubble that could have implications on the sustainability of this six-year bull market.Consider this, the most popular ETF in the sector—the Nasdaq Biotechnology iShares (IBB)—hit an all-time intraday high Friday of $374.62. […]
A very interesting day in the markets as the S&P 500 fell 1.46% and the NASDAQ 2.37%. Biotechs were crushed today – we’ve been saying the higher they go the more risk they get as they have been on a mostly interrupted run for 4+ years. That said you just never know when they will correct and even if it’s […]
In what looks like a sequel to March 2014, high-flying biotechnology stocks and exchange traded funds are retreating amid talk of frothy valuations and a biotech bubble.At least temporarily, Friday March 20 marked the top for several of the largest biotech ETFs. That is when big-name ETFs, such as the iShares Nasdaq Biotechnology ETF (IBB) , the largest biotech ETF, […]
Biotech stocks have been on fire in 2015. In the Biotech & Pharmaceuticals sector of the Russell 2000 Growth Index, there are over sixty stocks up by more than 30% this year. More than thirty stocks are up greater than 50% while six have more than doubled.The iShares Biotechnology ETF (IBB) is already up more than 20% less than 3 […]
Akin Oyedele
Mar. 23, 2015, 2:21 PM
0
Biotech stocks are on fire.That’s given some analysts flashbacks of 2000, when tech valuations were red hot, but it didn’t end well because they crashed.Michael Batnick over at The Irrelevant Investor posted this chart Monday that compares the rally in tech stocks then to biotechs in recent years.He describes the biotech rally:”In the 168 weeks since […]
Welcome to Friday. Here are three things to keep an eye on during the trading day.Two of today’s three are animated by near-opposite human cravings, but both have been crucial drivers of this bull market: biotech stocks and REITs.Number 1:Biotechs are all about a hoped-for future, the promised huge payoff from smarts and risk-taking, magic molecules to extend lives and […]
The biotechnology story is one that continues to highlight evolving growth opportunities in the medical field. Whether you are a believer in the high valuations or not, these stocks have consistently posted double digit gains for more than half a decade and enthralled investors with their resiliency. That makes biotechnology companies worthy of consideration for those that are seeking high […]
A pause in the dollar rally helped benchmarks start the week on a positive note. The U.S. dollar weakened ahead of the Federal Open Market Committee’s meeting that is scheduled this week. Rally in international markets also boosted investor sentiment. Separately, gains among bio-tech stocks boosted the Nasdaq. Meanwhile, discouraging reports on manufacturing and housing failed to dent investor confidence.For […]
Biotech stocks have been on a tear lately, with the SPDR S&P Biotech (ETF) (NYSEARCA:XBI) outrunning the S&P 500 about 45% to 10% over the past 10 months. And momentum still is on biotechs’ side, with 57% of the XBI’s components trading above their respective 50-day moving average. For perspective, the S&P 500 only boasts 41% on that front, and […]
